| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |